Sixteen researchers of Amsterdam UMC have been awarded a TKI-PPP grant between € 300.000 and € 750.000 to perform a research project in collaboration with an industrial party. The funding is provided by the NL government (Ministry of Economic Affairs) through the Rijksdienst voor Ondernemend Nederland (RVO) and the Topconsortium voor Kennis en Innovatie Life Sciences & Health (TKI-LSH, a.k.a. Health-Holland).
Examples of honored projects are the development of a novel nanovaccine that will result in a better treatment of cancer patients, longer survival and better quality of life, a machine learning technique that measures signals through EHG which will be able to predict premature labor based on historical cases and validation of a new treatment option for Alzheimer’s disease uniquely based on naturally occurring brain plasticity mechanisms.
In October 2019 the call for the Amsterdam UMC TKI grant 2020 opened. The Amsterdam UMC TKI grants for PPP projects are available to all Amsterdam UMC researchers who wish to perform a research project in collaboration with an industrial party. The grant is to stimulate Amsterdam UMC researchers to perform research projects together with companies in Public-Private Partnerships (PPP).
For the first time the TKI grant procedures from AMC and VUmc were combined. This also meant that the grant amounts available to both UMC’s were put together, creating a pot of approximately 9 million euros to be divided over our best PPP-research proposals.
During both selection rounds (pre- and final application), each proposal was judged by four jury members, consisting of two scientists selected from the eight Amsterdam UMC alliance institutes, an IXA business developer and an outside expert on impact (e.g. a life sciences venture capitalist).
Knowing that applying requires a serious effort of the researchers, we were very happy and proud to receive a total of 60 applications. The jury first selected 29 final proposals to go to the final round, after which the following 16 proposals could be awarded:
We wish all winning applicants lots of success performing their projects!
Water, comprising over 70% of our planet, is the source of all life. The presence of emerging contaminants in our water, including pharmaceuticals, pose serious health and environmental risks, such as DNA damage, reproductive issues, and cancer. New equipment to detect these contaminants developed by VU researchers has been sold to other research groups all over the world. Now the researchers are taking the next step, together with IXA, to expand sales to water companies worldwide as well as other applications such as food and drug discovery research.
NewsAre you looking for a testing ground for your innovation? SAIL and the Amsterdam Marathon present an excellent opportunity to test your ideas. These major events attract millions of visitors and come with sustainability, accessibility, and logistical challenges that need fresh solutions. The In Residence Events program allows you to test your innovation during these […]
NewsThe Academic Workplace Rudolf Berlin Center (AW RBC) aims to make a meaningful contribution by supporting young people with learning disabilities through enhanced education and care.
News